Assura Regulatory News (AGR)

6 April 2021

Assura plc

Directorate Changes

Assura plc ("Assura" or the "Company"), the UK's leading primary care property investor and developer, announces that Jenefer Greenwood intends to retire as non-executive director of the Company at the conclusion of the 2021 Annual General Meeting ("AGM") on 6 July 2021.

Jenefer was appointed to the Board in 2012 and serves as Chair of the Remuneration Committee. Louise Fowler, who joined the Board in June 2019, will take over as Chair of the Remuneration Committee after the AGM.

To support Assura's ambitious growth agenda, the board intends to appoint Emma Cariaga, Noel Gordon and Dr Sam Barrell CBE as non-executive directors on 1 May 2021.

Emma is the Joint Head of Canada Water Development on the Executive Committee of British Land and brings strong property skills and experience to Assura. Prior to British Land she worked at LandSec and in development and land management at Barratt and Crest Nicholson.

Noel is a recognised figure across the UK health system, with a strong background in digital technologies across several industries. His previous positions include Global Managing Director in Accenture, Chair of NHS Digital and as a non-executive director on the Board of NHS England.

Sam is the Chief Operating Officer of the Crick Institute responsible for leading the operational management and running of the institute. Prior to the Crick Institute she was Chief Executive of the Taunton and Somerset NHS Foundation Trust and is currently a non-executive director of York Health Economics Consortium, a subsidiary of York University.

Both Noel and Sam bring direct experience of the NHS and the provider landscape.

Ed Smith, Non-Executive Chairman, commented: "I would first sincerely like to thank Jenefer for her significant contribution to Assura over the last nine years, a period during which the Group has been transformed and its future growth prospects have never looked better. We all wish her the very best.

"As Assura moves to the next phase of its growth, we look forward to welcoming Emma, Noel and Sam to the Board, who will bring an extensive array of new skills and expertise and provide crucial counsel as Assura continues to create the future community health service space for the country."

There are no further disclosures required pursuant to paragraph 9.6.13 R of the Listing Rules.

- Ends -

For more information, please contact:

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.